CTOs on the Move

Phathom Pharmaceuticals

www.phathompharma.com

 
Phathom Pharmaceuticals, launched in 2019 by Frazier Healthcare Partners and Takeda Pharmaceuticals, is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal (GI) diseases and disorders. The company is advancing the investigational agent vonoprazan, a novel potassium-competitive acid blocker (P-CAB). Vonoprazan has the potential to address multiple unmet needs among patients with gastroesophageal reflux disease (GERD) and other acid-related disorders.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Funding

Phathom Pharmaceuticals raised $50M on 05/15/2019
Phathom Pharmaceuticals raised $90M on 05/15/2019

Similar Companies

Greater Chattanooga Orthodontics

Let us help make your smile beautiful TODAY! At Greater Chattanooga Orthodontics our commitment to excellence is apparent in all that we do. Our friendly staff can help develop a personalized plan for your specific orthodontic needs. Call TODAY to ...

Cytheris

Cytheris is a Rockville, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Aratana Therapeutics

Aratana Therapeutics, Inc. is a pet therapeutics company focused on licensing, developing and commercializing innovative therapeutics for cats and dogs.

Sanofi

3129 Sanofi SA is a French multinational healthcare company headquartered in Paris, France.

PDi-Pharmaceuticals

PDi-Pharmaceuticals is a Aurora, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.